Skip to main content
. Author manuscript; available in PMC: 2019 Jul 7.
Published in final edited form as: J Theor Biol. 2018 Apr 1;448:38–52. doi: 10.1016/j.jtbi.2018.03.035

Figure 5.

Figure 5

Case 4 (metronomic CDDP and dFdC) after 7 days post treatment initiation. The drug concentrations are shown for the extracellular (μM), intracellular (fMoles/cell), and DNA-bound (fMoles/cell) compartments as defined at this timepoint by the corresponding pharmacokinetic equations. While the proliferation region is comparable to day 1, the overall tumor is smaller. The dFdC extracellular concentration reflects the second dose at this timepoint.